miR-204 Shifts the Epithelial to Mesenchymal Transition in Concert With the Transcription Factors RUNX2, ETS1, and cMYB in Prostate Cancer Cell Line Model

Journal of Cancer Research
doi 10.1155/2014/840906
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

miR-573 Inhibits Prostate Cancer Metastasis by Regulating Epithelial-Mesenchymal Transition

Oncotarget
Oncology
2015English

“Mesenchymal Stromal Cell Engagement in Cancer Cell Epithelial to Mesenchymal Transition”

Developmental Dynamics
Developmental Biology
2017English

Epithelial-Mesenchymal Transition in Prostate Cancer: An Overview

Oncotarget
Oncology
2017English

IKK Inhibitor Suppresses Epithelial-Mesenchymal Transition and Induces Cell Death in Prostate Cancer

Oncology Reports
MedicineCancer ResearchOncology
2016English

Parathyroid Hormone–like Hormone Induces Epithelial-To-Mesenchymal Transition of Intestinal Epithelial Cells by Activating the Transcription Factor Runx2

American Journal of Pathology
Forensic MedicinePathology
2018English

Wild-Type P53 Suppresses the Epithelial-Mesenchymal Transition and Stemness in PC-3 Prostate Cancer Cells by Modulating miR-145

International Journal of Oncology
Cancer ResearchOncology
2013English

Mechanism of Epithelial‑mesenchymal Transition Inhibited by miR‑203 in Non‑small Cell Lung Cancer

Oncology Reports
MedicineCancer ResearchOncology
2019English

miR-204 Regulates Epithelial-Mesenchymal Transition by Targeting SP1 in the Tubular Epithelial Cells After Acute Kidney Injury Induced by Ischemia-Reperfusion

Oncology Reports
MedicineCancer ResearchOncology
2016English

The Role of the miR-200 Family in Epithelial-Mesenchymal Transition

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy